Category: ACN Newswire

SINGAPORE, May 18, 2026 - (ACN Newswire via SeaPRwire.com) - S CUBE Capital, a Singapore-based fund management firm regulated by the Monetary Authority of Singapore (MAS), is pleased to announce its strategic acquisition by InCred Capital, the wealth and asset management arm of the InCred Group, subject to regulatory approvals.This milestone brings together S CUBE Capital’s award-winning expertise in fixed income and alternative investments with InCred’s institutional reach, global wealth platform, and deep client franchise across India, Southeast Asia, the Middle East, and London.S CUBE Capital’s flagship fixed income fund was ranked the No. 1 in Asia Pacific by Bloomberg for the year ending January 2026. The firm was also named “Best Asset Management Firm – Singapore & Southeast Asia” by WealthBriefingAsia. Through this acquisition, S CUBE Capital’s clients and partners will benefit from a stronger institutional platform, broader investment capabilities, and a more seamless bridge for capital flows across key regional corridors.As part of the transition, S CUBE Capital’s Co-founders, Hemant Mishr and Balaji Swaminathan, along with key members of the S CUBE team, will join InCred Global Wealth. Hemant Mishr and Balaji Swaminathan will assume the roles of Joint Vice Chairmen of the global asset management business and their continued leadership will ensure stability, continuity, and commitment to S CUBE’s investors.Balaji Swaminathan and Hemant Mishr said in a joint statement “By combining S CUBE Capital’s specialized fixed-income and alternatives expertise with InCred’s institutional-grade infrastructure and global wealth platform, we are significantly expanding our ability to offer bespoke investment strategies and diversified investment products. For our investors, this means access to a broader opportunity set, deeper institutional support, and the continued high-touch service model that has defined S CUBE Capital.”“We have acquired S CUBE Capital to further strengthen our offshore product suite and global alternatives platform. As we continue to scale from a position of strength in India, S CUBE’s proven expertise in fixed income and alternatives enhances our global asset and wealth management platform and strengthens our ability to offer clients differentiated offshore investment opportunities across key regional corridors,” said Bhupinder Singh, founder, InCred Group.Srikantan Selvamani, CEO of InCred Global Wealth, added: “S CUBE Capital’s regulated fund platform, strong investment track record, and deep expertise in fixed income and alternative investments make it a natural fit for our global wealth business. Together, we are building a differentiated cross-border platform designed to serve the evolving needs of UHNIs, family offices, and institutional investors.”InCred Global Wealth operates across Singapore, Dubai, and London, offering wealth and asset management solutions spanning investments, credit, and legacy planning for ultra-high-net-worth individuals (UHNIs), high-net-worth individuals (HNIs), family offices, and institutional investors.The business currently oversees more than Rs 1 lakh crore (approximately US$10.5 billion) in wealth assets under management and approximately Rs 10,000 crore (US$1 billion) in asset management AUM.About SCUBE Capital(https://scubecapital.com/)S CUBE is a global fund management company domiciled in Singapore and regulated by the Monetary Authority of Singapore (MAS). We are a strong and dedicated team of internationally experienced experts delivering institutional investment expertise to client. Our team has managed investments of over USD50 billion in our previous roles and has a cumulative experience of over 100years in Global Financial Markets across assets includingCredit, Equities, Fixed Income,Rates,FXand Commodities.Media Contact:Namrata SharmaNamrata.sharma@adfactorspr.com+6581383034 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, May 16, 2026 - (ACN Newswire via SeaPRwire.com) - Against the backdrop of continued momentum in artificial intelligence and the robotics industry, Shoucheng Holdings (697.HK) released its first-quarter 2026 report on May 15. The report highlighted the company’s operational resilience and financial safety margin, further strengthening market expectations for a long-term revaluation of the company.In terms of core operating data, the company continued to improve its earnings quality. Excluding the impact of one-off gains, Shoucheng Holdings’ net profit attributable to shareholders rose 18% year on year in the first quarter, reflecting the steady improvement in the recurring profitability of its core businesses.Market observers believe this indicates that the company’s recent deployments in infrastructure asset management, industrial park operations, robotics, and intelligent manufacturing ecosystem investments are gradually entering a stage of return realization. Its ability to maintain stable profit growth at the operating level demonstrates a degree of counter-cyclical resilience in its business structure.As of the end of the first quarter of 2026, Shoucheng Holdings held approximately HK$7.279 billion in cash and cash equivalents, while its interest-bearing debt ratio was only 6.3%, reflecting a sound overall asset-liability structure. The company’s low leverage and high cash reserves not only strengthen its ability to withstand external market volatility, but also provide sufficient resources for continued investment in emerging industries, the expansion of its REITs ecosystem, and the advancement of its robotics industry chain layout.The company has continued to implement a high shareholder-return strategy. The board of directors declared a special dividend of HK$470 million, while the company repurchased approximately HK$175 million worth of shares during the first quarter. These actions reflect management’s strong confidence in the company’s future development and cash flow position. For Hong Kong equity investors, in a market environment that remains volatile, companies combining growth potential with stable shareholder returns are often more likely to attract medium- and long-term capital.With Shoucheng Holdings’ first-quarter results continuing to follow the three main themes of earnings recovery, financial stability, and enhanced shareholder returns, market observers believe that the company’s valuation still has room for continued revaluation as robotics commercialization, REITs asset recycling, and infrastructure operation capabilities are further unlocked. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

NESHER, ISRAEL, May 16, 2026 - (ACN Newswire via SeaPRwire.com) - Tabor Electronics today announced the commercial release of its Anti-Drone Test and Evaluation (T&E) solution, introducing a software-defined approach to validating counter-unmanned aircraft systems (C-UAS). Built on the company's Proteus™ Software Defined Radio (SDR) platform, the solution enables defense and security organizations to test and deploy counter-drone technologies in rapidly changing threat environments.As low-cost drones proliferate and communication protocols evolve, traditional hardware-bound test environments are struggling to keep pace. Tabor's platform replaces these constraints with a programmable framework that allows engineering teams to emulate and validate real-world RF scenarios in controlled lab environments-reducing reliance on extended field testing while accelerating development timelines.Originally developed in collaboration with leading anti-drone technology companies, the solution has already been proven in active development and integration workflows. Its commercial release brings a field-tested approach to organizations across defense, homeland security, public safety, and critical infrastructure.At the core of the platform is Tabor's Proteus SDR architecture, combining wideband RF signal generation and acquisition with real-time FPGA processing, deep memory, and high-throughput data movement in a compact COTS system. This integration enables closed-loop testing, where detection and mitigation techniques can be continuously validated and refined under realistic RF conditions.A Shift to Software-Defined ValidationTabor's solution changes how C-UAS systems are tested by moving validation into the lab and enabling rapid iteration through software. New threat scenarios can be introduced without hardware changes, allowing teams to adapt quickly while maintaining consistency between lab validation and real-world performance.This approach delivers clear operational benefits:Faster development and integration cyclesReduced dependence on field testingEnable predictable system performance before deploymentExtended lifespan of test infrastructureBy consolidating multiple RF test functions into a single scalable SDR platform, organizations can also reduce tool fragmentation and improve asset utilization across programs.Proteus SDR Platform OverviewThe Proteus platform is based on a direct digital RF architecture, supporting wide-frequency signal generation and acquisition with high instantaneous bandwidth for accurate threat emulation. Programmable FPGA resources enable real-time adaptability, while flexible form factors-including benchtop, desktop, and PXI-support both component-level development and full system evaluation. Multi-channel phase-coherent operation enables complex, synchronized test scenarios.Mark Elo, Chief Product Officer at Tabor Electronics, commented:"Counter-drone systems are being deployed into environments where threats evolve faster than traditional validation methods can keep up. We built this platform to close that gap-giving teams the ability to test against what's next, not what's already known."About Tabor ElectronicsFounded in 1971, Tabor Electronics is a global provider of signal generation and acquisition solutions serving defense, aerospace, communications, and advanced research markets. The company is known for compact, scalable architecture, long platform lifecycles, and close collaboration with OEMs and system integrators worldwide.For more information: https://info.taborelec.com/drone-test-guideTabor Electronics will present its Anti-Drone Test and Evaluation solution at AOC Europe, 19th -21st May, Helsinki, Finland at Booth 5S13.Follow Us on LinkedIn: https://www.linkedin.com/company/tabor-electronics/Media and Investor Contact:Mark Elo, CPO628-208-6418info@taborelec.comwww.taborelec.comSOURCE: Tabor Electronics Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, May 15, 2026 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX: 1952.HK) announced that on 14 May 2026, based on strong confidence in the company’s future prospects and long-term development, Mr. Wei Fu, a non-executive Director, the honorary chairman of the Board and a substantial shareholder of the company, purchased 660,000 ordinary shares of the company on the open-market for a total consideration of approximately HK$20.7 million, representing an average price of approximately HK$31.25 per Share. Mr. Wei Fu pointed out that he does not rule out the possibility of further increasing his shareholdings in the company when appropriate.This marks Mr. Wei Fu’s second share purchase in Everest Medicines in 2026. Previously, on March 27, he acquired 860,000 shares of Everest Medicines at an average price of approximately HK$38.12 per share, for a total consideration of approximately HK$32.7 million.Mr. Wei Fu’s consecutive share purchases within the year reflect his firm confidence in both Everest Medicines' strategic direction and operational achievements. At the end of 2025, Everest Medicines unveiled its 2030 strategy, which clearly adopts a dual-engine approach driven by both business development collaborations and in-house R&D. By 2030, the company aims to achieve revenue exceeding RMB15 billion and expand its commercialized product portfolio to more than 20 products, while continuing to focus on high-growth therapeutic areas including nephrology, cardiovascular and metabolic diseases. In December 2025, the management team and substantial shareholders collectively increased their shareholdings in the market, signaling long-term confidence in the company’s development.On the operational front, Everest Medicines reported total revenue of RMB1.707 billion for the full year of 2025, representing a year-over-year increase of 142%. The company also achieved annual profitability for the first time on a non-IFRS basis, recording a profit of RMB187 million, while operating cash flow turned positive in the fourth quarter. Sales revenue of NEFECON® reached RMB1.443 billion, representing growth of more than 300% year-over-year, making it the first non-oncology innovative drug in China to exceed RMB1 billion in annual sales in its first year of inclusion in the National Reimbursement Drug List (NRDL). Meanwhile, XERAVA® achieved sales revenue of RMB262 million, with in-hospital sales increasing by 44% year-over-year. These results further validate the company’s strengthening commercialization capabilities and continued execution momentum.The management team’s collective shareholding increases and Mr. Fu’s consecutive share purchases in 2026 demonstrated strong confidence in the Company’s long-term prospects. Supported by strong operational execution and strategic implementation, Everest Medicines’ medium- to long-term growth trajectory is becoming increasingly clear. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SINGAPORE, May 15, 2026 - (ACN Newswire via SeaPRwire.com) - Travel goals often begin as ideas scribbled in a notebook or saved Instagram posts but turning them into real experiences can take thoughtful planning. One practical way travellers in Singapore explore these goals is by understanding how Travel Credit Cards can fit into their overall travel checklist. When used mindfully, the right card rewards can help reduce travel-related expenses and make trips feel more achievable. From flights and accommodation to daily spending abroad, a structured approach can help travellers make the most of what they already spend.This checklist is designed to help review travel plans and see how card rewards can support those goals in a realistic, manageable way.Define Your Travel Goals ClearlyClear travel goals provide direction and make planning feel less overwhelming. Instead of a vague plan to "travel more," it helps to identify destinations, timelines, and travel styles. For instance, a short regional trip to Bangkok or Bali may involve different costs and priorities compared to a longer holiday to Europe or Australia. In Singapore, a return flight within Southeast Asia can range between SGD 200 and SGD 500, while long-haul flights may cross SGD 1,200.Understand How Travel Rewards Fit Into Your PlansTravel rewards work best when they match existing spending patterns rather than forcing new habits. Many Travel Credit Cards in Singapore offer reward points or miles on everyday categories, such as dining, online shopping, and transport. Over time, these points can help offset flight bookings or hotel stays. This makes it easier to assess how everyday spending may contribute to future travel plans.Track Your Expenses and Reward PotentialTracking spending is an important part of reviewing how realistic travel goals are. Monthly expenses, such as groceries, utilities, and subscriptions, often total between SGD 1,500 and SGD 2,500 for many households in Singapore. When these expenses are channelled through cards offering travel rewards, points can accumulate gradually. Keeping a simple monthly record can also highlight which categories generate the most rewards.Check Reward Redemption Options and FlexibilityNot all rewards work the same way, so you should review redemption options. Some cards allow points to be converted into airline miles, while others offer travel vouchers or statement credits for travel bookings. Flexibility matters, especially for travellers who prefer multiple airlines or travel dates. Understanding the terms and conditions of rewards also helps clarify what is actually usable for your plans.Review Travel-Related Benefits Beyond RewardsMany Travel Credit Cards come with additional benefits, such as airport lounge access, travel insurance coverage, or discounts on hotel bookings. For example, complimentary lounge access at Changi Airport can help reduce pre-flight expenses, where meals alone may cost SGD 20-40. These features may be useful for travellers who value comfort and convenience alongside rewards.Plan for Overseas Spending and Currency CostsOverseas spending is an important part of any travel checklist, especially when travelling frequently. Foreign currency fees often range between 2.5% and 3.5% per transaction, which can add up quickly on longer trips. Some travel-focused cards offer lower foreign currency fees or bonus rewards for overseas spending. This is worth reviewing before choosing a card for regular use abroad.Review Annual Fees Against Real ValueAnnual fees are an important consideration when reviewing travel-related cards. In Singapore, annual fees for Travel Credit Cards can range from SGD 150 to SGD 500. While higher-fee cards often come with more generous rewards or perks, the value depends on individual travel frequency. A traveller taking one or two trips a year may find sufficient value in mid-range options. Reviewing fee waivers, renewal bonuses, and reward redemption potential can give a clearer picture of overall value.Turning Plans Into Meaningful Travel ExperiencesTravel planning does not have to feel complicated or financially overwhelming. With a clear checklist and realistic expectations, travellers in Singapore can review how everyday spending aligns with their travel goals. Travel Credit Cards, when chosen thoughtfully, can help make trips more accessible by offsetting certain costs and adding convenience. The key lies in understanding rewards, tracking progress, and revisiting goals regularly.Disclaimer: This content is published by iQuanti Singapore Pte. Ltd., an external marketer engaged and compensated by UOB Ltd.Contact Information:Name: Sonakshi MurzeEmail: Sonakshi.murze@iquanti.comJob Title: ManagerSOURCE: iQuanti Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年5月15日 - (亚太商讯 via SeaPRwire.com) - 云顶新耀（HKEX 1952.HK）发布公告，基于对公司未来前景及长远发展的坚定信心，公司非执行董事、董事会荣誉主席兼主要股东傅唯先生于2026年5月14日通过公开市场购入公司普通股66万股，并表示不排除在适当时候进一步增持。本次交易总金额约为2070万港元，平均价格约为每股31.25港元。这是傅唯2026年以来对云顶新耀的第二次增持。此前3月27日，他已以每股约38.12港元购入云顶新耀86万股股份，总金额约为3270万港元。主要股东傅唯年内接连增持，充分体现了其对云顶新耀战略方向与业绩成果的双重认可。云顶新耀于2025年底发布2030年发展战略，明确以“BD合作+自研”双轮驱动，目标至2030年营收突破150亿元，商业化产品超过20款，持续聚焦肾科、心血管及代谢等蓝海领域。2025年12月，管理层及主要股东已通过市场集体增持表达长期信心。业绩层面，云顶新耀2025年全年总收入达人民币17.07亿元，同比增长142%；非国际财务报告准则下首次实现年度盈利，录得盈利1.87亿元，经营性现金流于第四季度成功转正。核心产品耐赋康®销售收入达14.43亿元，同比增长超300%，成为国内纳入医保首年即超10亿元的非肿瘤药物；依嘉®实现销售收入2.62亿元，院内销售同比增长44%。这些数据充分验证了公司商业化能力的持续兑现与不断增强。从战略发布时的管理层集体增持，到2026年内傅唯的两次独立加仓，股东及管理层持续以增持行动彰显对公司前景的信心。在业绩兑现与战略落地的双重支撑下，云顶新耀的中长期发展路径愈发清晰。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Highlights:WellCare Today brings established RPM, RTM and CCM infrastructure with wearable technology integrations and connected monitoring solutionsCombination expected to integrate Wellgistics Health recently announced MSO initiative with Kare Clinicals and its network of 6,500+ independent pharmaciesProposed platform designed to enhance patient engagement, medication adherence, remote monitoring and longitudinal care coordinationProposed transaction valued at approximately $15 millionStrategic initiative intended to create additional clinical revenue opportunities for participating pharmacies and providersTAMPA, FLA., May 15, 2026 - (ACN Newswire via SeaPRwire.com) - Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced that it has executed a non-binding letter of intent ("LOI") to acquire WellCare Today. The proposed transaction structure includes a structured cash payment of $3 million, with the balance to be satisfied through a performance-based earnout issued in preferred stock.WellCare Today is a healthcare technology and remote monitoring company focused on chronic care management ("CCM"), remote patient monitoring ("RPM"), and remote therapeutic monitoring ("RTM") programs. The company delivers HealthAssist®, an advanced remote health monitoring platform embedded within standalone Samsung Galaxy Watch devices as part of its broader Health Monitoring & Emergency Support Ecosystem. The platform enables passive, continuous monitoring of key health metrics including heart rate, blood oxygen levels, temperature, sleep patterns, activity tracking, and self-reported medication adherence through Medicare-reimbursable RPM and RTM programs. No assurance can be given that any particular patient, provider, pharmacy, service, device or workflow will qualify for reimbursement.Under the proposed transaction structure, Wellgistics Health intends to integrate WellCare Today's HealthAssist® platform and RPM, RTM and CCM capabilities with the Company's recently announced MSO pilot collaboration involving Kare Clinicals, a division of Kare PharmTech, LLC, as well as its network of more than 6,500 independent pharmacies. The combined infrastructure is intended to support scalable patient engagement, medication adherence initiatives, longitudinal monitoring programs, chronic disease management, and enhanced care coordination workflows across provider and pharmacy channels utilizing connected wearable technologies and remote monitoring infrastructure.The proposed transaction is also expected to create opportunities for participating pharmacies within the Wellgistics Pharmacy Network to engage in clinical service programs associated with RPM, RTM and CCM initiatives, while enabling providers to access scalable care coordination, monitoring, and reimbursement infrastructure. The companies believe the proposed collaboration may establish a more connected healthcare ecosystem aligning patients, pharmacies, providers, wearable technologies, and longitudinal care coordination services through technology-enabled engagement and remote monitoring platforms.The LOI is non-binding, and completion of the proposed transaction remains subject to customary due diligence, negotiation and execution of definitive agreements, board approvals, financing considerations, and other customary closing conditions. There can be no assurance that a definitive agreement will be executed or that the proposed transaction will be completed as currently contemplated, or at all.About Wellgistics Health, Inc.Wellgistics Health (NASDAQ:WGRX) is a health information technology leader integrating its proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx™ into its blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription drug dispensing journey. Its integrated platform connects more than 6,500 pharmacies and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility verification, onboarding, adherence support, prior authorization, and cash-pay fulfillment designed to improve patient access and transparency across the prescription ecosystem.About WellCare Today, LLCWellCare Today is a healthcare technology company delivering HealthAssist®, an advanced remote health monitoring platform embedded within standalone Samsung Galaxy Watch devices as part of its comprehensive Health Monitoring & Emergency Support Ecosystem. HealthAssist® enables passive, continuous monitoring of key health metrics including hourly heart rate, hourly blood oxygen levels, temperature, daily steps, sleep patterns, and self-reported medication adherence. Integrated with Remote Therapeutic Monitoring (RTM) and Remote Patient Monitoring (RPM) programs reimbursable by Medicare, HealthAssist® delivers an affordable, scalable solution designed to support seniors and individuals managing chronic health conditions.All RPM, RTM, CCM and related care-coordination services are expected to be furnished, supervised, documented and billed by appropriately licensed providers and participating entities in accordance with applicable federal and state healthcare laws, Medicare and payor requirements, fraud and abuse laws, privacy and data-security requirements, and professional practice rules. The Company does not provide medical advice through this press release, and participation in any program will be subject to applicable clinical, contractual, regulatory and reimbursement requirements.Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. Forward-looking statements include, without limitation, statements regarding the proposed acquisition of WellCare Today, LLC; the anticipated structure, valuation, consideration, preferred-stock terms and potential timing of any transaction; the Company's ability to complete due diligence, negotiate and enter into definitive agreements, obtain board approvals, secure financing, satisfy closing conditions and complete the proposed transaction; the potential integration of WellCare Today's platform, technology, personnel, programs and workflows with the Company's MSO, pharmacy network, provider and healthcare technology initiatives; the potential use of HealthAssist® and connected wearable technologies in RPM, RTM, CCM, medication adherence, patient engagement and care-coordination programs; the potential participation of pharmacies, providers, patients and payors; the potential availability of reimbursement for RPM, RTM, CCM or related services; the potential creation of revenue opportunities; and the Company's growth strategy, business plans and future performance.Forward-looking statements may be identified by words such as "may," "could," "would," "should," "expect," "anticipate," "believe," "intend," "plan," "project," "estimate," "potential," "opportunity," "target," "forecast," "continue," "will" and similar expressions. These statements are based on current expectations, assumptions and estimates and are subject to risks and uncertainties, many of which are beyond the Company's control. Important factors that could cause actual results to differ materially include, but are not limited to: the risk that the parties do not enter into definitive agreements; the risk that the letter of intent is terminated or does not result in a completed transaction; the risk that the proposed valuation, consideration, preferred-stock terms or other transaction terms change materially; the risk that required financing, board approvals, third-party approvals or regulatory approvals are not obtained on acceptable terms or at all; the risk that Nasdaq shareholder approval or other Nasdaq requirements may apply depending on the final transaction terms; the risk that acquired technologies, programs or operations are not successfully integrated; the risk that anticipated benefits, synergies, provider adoption, pharmacy participation, patient engagement, reimbursement or revenue opportunities are not realized; risks associated with healthcare regulation, Medicare and payor requirements, fraud and abuse laws, privacy and data-security requirements, professional practice rules, device performance, third-party technology dependencies and changes in reimbursement policy; and other risks and uncertainties described in the Company's filings with the U.S. Securities and Exchange Commission.Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law.Wellgistics Media & Investor ContactMedia: media@wellgisticshealth.comInvestor Relations: IR@wellgisticshealth.comSOURCE: Wellgistics Health, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

重点：WellCare Today 拥有成熟的 RPM、RTM 和 CCM 基础设施，并具备可穿戴技术集成和联网监测解决方案此次整合预计将把 Wellgistics Health 近期与 Kare Clinicals 联合推出的 MSO 计划，与其覆盖 6,500 多家独立药房的网络相结合拟建平台旨在提升患者参与度、用药依从性、远程监测及纵向护理协调能力拟议交易估值约为 1,500 万美元该战略举措旨在为参与的药房和医疗服务提供者创造额外的临床收入机会佛罗里达州坦帕市, 2026年5月15日 - (亚太商讯 via SeaPRwire.com) - 领先的医疗健康技术与药品分销公司 Wellgistics Health, Inc.（纳斯达克代码：WGRX）（以下简称“Wellgistics”或“公司”）今日宣布，已签署一份收购 WellCare Today 的非约束性意向书（“LOI”）。拟议的交易结构包括300万美元的现金支付，剩余部分将通过以优先股形式发放的基于业绩的延期付款来结算。WellCare Today是一家专注于慢性病管理（“CCM”）、远程患者监测（“RPM”）及远程治疗监测（“RTM”）项目的医疗科技与远程监测公司。该公司提供HealthAssist®——一款嵌入独立三星Galaxy Watch设备的先进远程健康监测平台，该平台是其更广泛的“健康监测与紧急支援生态系统”的重要组成部分。该平台通过符合 Medicare 报销标准的 RPM 和 RTM 项目，能够对心率、血氧水平、体温、睡眠模式、活动追踪以及患者自报的用药依从性等关键健康指标进行被动、持续的监测。无法保证任何特定的患者、医疗服务提供者、药房、服务、设备或工作流程均符合报销资格。根据拟议的交易架构，Wellgistics Health计划将WellCare Today的HealthAssist®平台及其RPM、RTM和CCM能力，与公司近期宣布的MSO试点合作项目进行整合。该合作涉及Kare PharmTech, LLC旗下子公司Kare Clinicals，以及其覆盖超过6,500家独立药房的网络。整合后的基础设施旨在利用互联可穿戴技术和远程监测基础设施，在医疗服务提供者和药房渠道之间支持可扩展的患者参与、用药依从性计划、纵向监测项目、慢性病管理以及增强的护理协调工作流程。拟议交易还预计将为Wellgistics药房网络内的参与药房创造机会，使其能够参与与RPM、RTM和CCM计划相关的临床服务项目，同时使医疗服务提供者能够访问可扩展的护理协调、监测和报销基础设施。双方认为，此次拟议的合作有望通过技术驱动的互动与远程监测平台，构建一个更紧密互联的医疗生态系统，将患者、药房、医疗服务提供者、可穿戴技术及纵向护理协调服务有机结合。该意向书不具约束力，拟议交易的完成仍需满足惯例尽职调查、最终协议的谈判与签署、董事会批准、融资安排及其他惯例交割条件。无法保证最终协议将得以签署，亦无法保证拟议交易将按当前设想完成，甚至可能无法完成。关于 Wellgistics Health, Inc.Wellgistics Health（纳斯达克代码：WGRX）是一家健康信息技术领域的领导者，其将专有的药房配药优化人工智能平台 EinsteinRx™ 整合至基于区块链的智能合约平台 PharmacyChain™ 中，以优化处方药配药流程。其集成平台连接了超过 6,500 家药房和 200 多家制造商，提供批发分销、数字处方路由、直接送达患者以及由人工智能驱动的枢纽服务，例如资格验证、患者入网、用药依从性支持、事前授权和现金支付履约，旨在改善患者在处方药生态系统中的可及性并提高透明度。关于 WellCare Today, LLCWellCare Today 是一家医疗科技公司，提供 HealthAssist® 服务——这是一个先进的远程健康监测平台，内置于独立的三星 Galaxy Watch 设备中，是其全面健康监测与紧急支援生态系统的重要组成部分。HealthAssist® 能够对关键健康指标进行被动、持续的监测，包括每小时心率、每小时血氧水平、体温、每日步数、睡眠模式以及用户自报的用药依从性。HealthAssist® 与 Medicare 可报销的远程治疗监测 (RTM) 和远程患者监测 (RPM) 项目集成，提供了一种经济实惠且可扩展的解决方案，旨在为老年人及慢性病患者提供支持。所有 RPM、RTM、CCM 及相关护理协调服务，均应由持有适当执照的医疗服务提供者及参与机构，依据适用的联邦和州医疗保健法律、Medicare 及支付方要求、反欺诈与反滥用法律、隐私及数据安全要求以及专业执业规则进行提供、监督、记录和计费。本公司不通过本新闻稿提供医疗建议，参与任何项目均须符合适用的临床、合同、监管及报销要求。前瞻性陈述本新闻稿包含《1995年私人证券诉讼改革法案》及其他适用联邦证券法所界定的前瞻性陈述。前瞻性陈述包括但不限于关于拟收购WellCare Today, LLC的陈述； 任何交易的预期结构、估值、对价、优先股条款及潜在时间安排；本公司完成尽职调查、协商并签署最终协议、获得董事会批准、筹集资金、满足交割条件并完成拟议交易的能力；WellCare Today的平台、技术、人员、项目及工作流程与本公司的医疗服务组织（MSO）、药房网络、医疗服务提供者及医疗技术计划的潜在整合； HealthAssist®及相关可穿戴技术在远程患者监测（RPM）、远程治疗管理（RTM）、慢性病管理（CCM）、用药依从性、患者参与及护理协调项目中的潜在应用；药房、医疗服务提供者、患者及支付方的潜在参与；RPM、RTM、CCM或相关服务潜在的报销可用性；潜在的收入机会；以及本公司的增长战略、业务计划和未来业绩。前瞻性陈述通常包含“可能”、“可能”、“将会”、“应该”、“预期”、“预计”、“相信”、“打算”、“计划”、“预测”、“估计”、“潜在”、“机会”、“目标”、“预测”、“继续” “将”及类似表述。此类陈述基于当前的预期、假设和估计，并受风险和不确定性影响，其中许多因素超出公司的控制范围。可能导致实际结果与预期存在重大差异的重要因素包括但不限于：各方未能签订最终协议的风险；意向书被终止或未能促成交易完成的风险； 拟议估值、对价、优先股条款或其他交易条款发生重大变更的风险；未能以可接受条款或完全无法获得所需融资、董事会批准、第三方批准或监管批准的风险；根据最终交易条款，可能需要获得纳斯达克股东批准或满足其他纳斯达克要求的风险；所收购的技术、项目或业务未能成功整合的风险； 预期收益、协同效应、供应商采用率、药房参与度、患者参与度、报销或收入机会未能实现的风险；与医疗保健法规、联邦医疗保险（Medicare）及支付方要求、反欺诈与滥用法规、隐私及数据安全要求、专业执业规则、设备性能、第三方技术依赖性以及报销政策变更相关的风险；以及本公司向美国证券交易委员会提交的文件中所述的其他风险和不确定性。前瞻性陈述仅反映其作出之日的观点，除适用法律要求外，本公司不承担更新或修订任何前瞻性陈述的义务。Wellgistics 媒体与投资者联系媒体：media@wellgisticshealth.com 投资者关系：IR@wellgisticshealth.com 来源：Wellgistics Health, Inc. Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, May 14, 2026 - (ACN Newswire via SeaPRwire.com) - Galaxy Payroll Group Limited (NASDAQ: GLXG) (“GLXG” or the “Company”), a provider of payroll outsourcing and employment services, today announced its unaudited financial results for the six months ended December 31, 2025.Financial Highlights· Revenue increased to HKD14.0 million (US$2.0 million), representing year-over-year growth of approximately 2%· Total number of customers increased from 196 to 210· Net loss improved significantly from HKD26.5 million (US$3.4 million) to HKD1.1 million (US$0.1 million)· Operating expenses declined substantially following normalization of prior-period non-recurring expenses· Net cash provided by operating activities was HKD1.25 million (US$0.2 million)· Cash balance increased to HKD33.2 million (US$4 million) as of December 31, 2025The Company’s employment services business continued to expand across multiple Asian markets, supported by growing demand for cross-border employment and outsourcing solutions.The substantial reduction in net loss compared to the prior period primarily reflected the absence of certain one-time research and development expenditures and listing-related costs incurred during the prior fiscal year.For the full interim unaudited financial statements for the six months ended December 31, 2025, please refer to the report of foreign issuers furnished by the Company with the United States Securities and Exchange Commission on the even day of this release.Business UpdateThe Company has also observed encouraging business activity entering 2026, including increases in client headcount across selected accounts and continued onboarding of projects in multiple markets. These observations are preliminary in nature and may not necessarily be indicative of future financial results.Capital PositionAs of December 31, 2025, the Company maintained cash and cash equivalents of approximately HKD33.2 million (US$4 million) and positive working capital. Management believes the Company’s current liquidity position supports its present operating plan and ongoing business development activities.Based on current expectations, the Company does not currently expect to require near-term external equity financing and has no present intention to establish an at-the-market (“ATM”) offering program over the next 12 months. This assessment remains subject to market conditions, business performance, and strategic considerations.Management CommentaryWai Hong Lao, Chief Executive Officer of GLXG, commented:“Our interim results reflect continued progress in stabilizing and strengthening our operating profile following our public listing. While revenue growth remained modest during the period, we achieved meaningful improvement in our cost structure and operating performance.We are encouraged by the continued expansion of our customer base, positive operating cash flow, and ongoing business activity entering 2026. We remain focused on disciplined execution, prudent capital management, and building long-term shareholder value.”About Galaxy Payroll Group LimitedGalaxy Payroll Group Limited is a provider of payroll outsourcing and employment services operating across multiple Asian markets.Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of applicable securities laws. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Factors that could cause such differences include, but are not limited to, market conditions, customer demand, competitive conditions, regulatory developments, financing conditions, and the Company’s ability to execute its business strategy. Forward-looking statements include statements regarding future business activity, growth expectations, liquidity, and financing intentions. The Company undertakes no obligation to update forward-looking statements except as required by law. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年5月14日 - (亚太商讯 via SeaPRwire.com) - 2026年5月11日，金山科技工业有限公司("金山科技"，00040.HK）签订一项 6.75 亿港元绿色及可持续发展表现挂钩贷款（"GSLL 银团贷款"）。此银团贷款由十家主要银行提供：恒生银行有限公司担任独家委任牵头安排行兼簿记行，牵头行为上海商业银行有限公司，共同安排行为马来亚银行，其他安排行包括彰化商业银行股份有限公司-香港分行、东莞银行(国际)有限公司、浙商银行股份有限公司（香港分行）、合作金库商业银行股份有限公司-香港分行、台湾新光商业银行股份有限公司-香港分行、第一商业银行股份有限公司-澳门分行及华南商业银行股份有限公司-国际金融业务分行。尽管全球环境充满挑战，此项6.75亿港元的GSLL银团贷款仍彰显银行业界对金山科技在落实与推进环境、社会及管治（"ESG"）方面所展现的承诺及良好往绩，持有坚定信心并给予有力支持。金山科技主席兼总裁罗仲荣表示："金山科技致力投入长远可持续发展，并已取得相当成效。这项 GSLL 银团贷款不仅是对我们策略方向的肯定，亦加强了我们追求创新融资方案和运营方式的能力，以支持可持续的业务增长。"金山科技副主席兼执行副总裁李耀祥表示："作为电池、音响及电子业的领先企业，金山科技致力将永续理念全面融入各个营运层面。 我们在推动落实永续策略上已取得稳健且可量化的进展，充分展现对履行企业公民责任的承诺，以及对创造长期价值的坚定决心。""我们提倡使用充电池，以减少浪费资源。GP Recyko 充电池系列已广受市场接受，而我们亦持续提升充电效率，让电池可在短短一小时内完成充电，进一步鼓励消费者改变习惯，由一次性电池转用充电池。""我们持推动环保包装：现时欧洲超过 1,000 种 GP 品牌消费类电池产品，已由纸料代替塑胶包装。 据此，我们成功录得 48 吨塑胶及 30 吨材料废弃物的年减幅。"GP 能源科技 ─ 集团的可持续能源方案业务 ─ 在本年一月达成重要里程碑，在中国东莞启用首座镍锌电池制造工厂，此举亦象征金山科技朝新一代镍锌电池解决方案的发展迈出重要一步，以镍锌高功率密度、高度可回收性及不易燃等特性，大大提升即时电源的表现。镍锌电池为数据中心及其他重要基础设施的不间断电源系统（Uninterruptible Power Supply, UPS）提供可靠且永续的供电方案。 GSLL 银团贷款将支持集团进一步推展镍锌电池业务，迈向更安全且永续的未来。金山科技将永续视为推动盈利与长期增长的重要因素。于2024/25年度，集团在范畴一及范畴二温室气体排放量相较 2023/24年度的减幅达 4%。集团将持续致力达成中期与长期减量目标，重点如下：• 于 2030 年或以前，相比 2023/24 年度的基准减少 20%；• 于 2040 年或以前，减少 60%；• 于 2050 年或以前，实现净零营运碳排放（即减少 100%）。金山科技致力环保减废，取得多项相关殊荣及认证，当中集团六间电池制造设施获得UL Solutions"废弃物零填埋"铂金或金级认证，显示其透过有效减少废物和分流策略，成功减少95-100%的堆填废弃物。 此外，金山电池及GP能源科技于2025/26年度同时取得EcoVadis铜牌。 集团亦持续加强工厂的太阳能装置，落实减碳目标。恒生银行商业银行业务总监李秀怡表示："此项银团融资安排反映市场对金山科技长远发展策略及可持续发展工作的信心。 恒生银行很荣幸担任本次交易的独家委任牵头安排行兼簿记行，提供以明确的可持续发展目标为导向、并激励达标表现的融资结构，同时支持集团持续投资于充电池制造业务。 作为长期合作伙伴，我们期待与金山科技紧密协作，推动融资与可持续发展的融合，为社区及持份者创造长远价值。"这项为期三年的 GSLL 绿色银团贷款设有分级奖励机制，金山科技每达到既定的 GSLL 银团贷款可持续发展目标时可享受利息减免。 集团计划将是次贷款所得款项用于强化财务状况、加速充电池及可持续能源方案业务发展、支持用于先进制造技术的长期投资、提升运营效率，并加强其对可持续商业实践的承诺。(中) 金山科技副主席兼执行副总裁李耀祥与十间主要银行签订6.75亿GSLL银团贷款(左七) 金山科技主席兼总裁罗仲荣感谢银行界支持促成是次 GSLL 银团贷款金山科技集团黄思珞 高级企业传讯经理电话：(852) 2485 5328电邮： charlotte_wong@goldpeak.comAJA Capital 艾明资本庾婉华 / 吕婉琪电话：( 852) 9500 4443 / 9155 5615电邮：avy.yu@ajacapital.com.hk / janet.louie@ajacapital.com.hk金山科技集团简介金山科技集团为一家电池及电子跨国企业，锐意成为提供电能及音响方案的领导者之一，并以可持续原则为发展重点，令人类生活更充实，更有动力。集团母公司金山科技工业有限公司[0040.HK]于1964年成立，并自1984年在香港上市。 金山科技现时拥有GP工业有限公司 86.18%*股权，作为其主要投资工具。GP工业在新加坡上市。金山科技直接持有 GP 能源科技国际有限公司，主力研发创新充电池技术及开发环保储能电池方案企业对企业(B2B)电池业务。GP工业则专注发展消费类电池、电子产品及扬声器业务。集团之主要产品类别如"GP超霸"电池、"GP 绿再"充电池、"KEF"高级扬声器和"Celestion"专业扬声器，已成为业内著名品牌。 金山科技集团之生产设施、产品研究发展及销售办事处遍布全球十多个国家。www.goldpeak.com(* 于 2026 年 5 月 11 日持有之股权) Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - May 14, 2026) - Euro Manganese Inc. (TSXV: EMN) (ASX: EMN) (FSE: E060) and its subsidiary Mangan Chvaletice, s.r.o. ("Mangan" and together the "Company", "Euro Manganese" or "EMN") is pleased to announce the results of a new Preliminary Economic Assessment ("PEA") for the development of its Chvaletice Manganese Project ("Chvaletice Manganese Project", "CMP", or "Project") in the Czech Republic.The PEA is a result of the Company's Optimization Program previously announced1, and builds on the extensive knowledge presented in the Company's Technical Report and Feasibility Study for the Chvaletice Manganese Project, Czech Republic, dated effective July 27, 2022[2], (the "2022 Feasibility Study"). The PEA responds to current market conditions and incorporates the Company's testing campaigns, demonstration plant learnings, and prospective customer testing and feedback to provide an updated preliminary and conceptual development path for the Chvaletice Manganese Project.With most permits secured, a finalized Environmental Impact Assessment ("ESIA"), and official designation as a Strategic Deposit under Czech law and a Strategic Project under the EU Critical Raw Materials Act, Euro Manganese is ready to respond to customers seeking a fully traceable battery-grade manganese supply chain, reducing dependence on Chinese sources and supporting strategic mineral independence objectives.The Chvaletice Manganese Project is well placed to take advantage of U.S. federal procurement and incentive frameworks that increasingly require that critical battery materials — including high-purity manganese used in electric vehicle and energy storage applications — be sourced from allied and US National Defense Act ("NDAA") compliant nations. The Czech Republic, as a NATO member and close U.S. ally, qualifies as an NDAA-compliant source country.HIGHLIGHTS(All economic values are in US dollars unless indicated otherwise)Strong Operating Margin of 48%, demonstrating resilience of the Project and the potential to generate significant returns across commodity price cycles.Robust Returns: Pre-tax IRR of 16.0% and Post-tax IRR of 13.8%, underpinned by a pre-tax NPV of $740M and post-tax NPV of $492M (8% discount rate), showing favorable preliminary economic indicators on historically conservative pricing assumptions.Higher Recoveries, 60% for High-Purity Manganese Sulphate Monohydrate (HPMSM) and 61% for High Purity Manganese Metal (HPEMM), reflecting additional metallurgical test work, operational learnings from the demonstration plant, and process engineering updates.Revised Flowsheet supports 50,000 tpa of HPEMM with full conversion to 150,000 tpa of HPMSM, aligning with battery industry demand while maintaining flexibility to deliver both HPEMM and HPMSM products as customer needs evolve.Newly incorporated magnesium carbonate ("MgCO3") resource as a by-product enables production of up to 20,000 tpa MgCO3, adding incremental value with minimal capital.CAPEX costs remain broadly consistent with the 2022 Feasibility Study, including with increased HPMSM output, despite an inflationary environment.OPEX reduced for per unit cost of HPMSM compared to the 2022 Feasibility Study, due to increased production of HPMSM and updated reagents and energy costs.Updated pricing assumptions demonstrates potential economic viability of the Project even under conservative current market conditions, underscoring its durability through price cycles.Phased development reduces upfront capital requirements, lowers funding risk, and allows further optimization before full-scale expansion.Phase II buildout planned shortly after Phase I commissioning to maximize project value and shareholder returns.Initial Capital, Phase One (50% capacity): $627.5M; Plant Capacity Expansion Capital, Phase Two (to 100% capacity): $197.8M.Annual nominal production: 150,000 tpa HPMSM.Project life: 26 years.Average life of project HPMSM price assumed at $2,888 per tonne.NEXT STEPSThe PEA has enabled the Company to optimize inputs based on current pricing, establishing the possibility for a two-stage construction strategy. This phased approach has the potential to allow for further optimization in phase two, lower upfront capital requirements, and enhance project economics by aligning investment with cash flow.The Company will now advance the Chvaletice Manganese Project further towards a full feasibility study, with a targeted completion in H1 2027.The Company will also continue to monitor high purity manganese markets and strategic sectors to which it contributes, including energy transition, grid-scale energy storage, e-mobility and aerospace and defence technologies.The Company will continue to engage with potential customers to secure additional offtake term sheets, pursue offtake agreements, and continue product testing.In addition, during 2026, the Company is focused on the following key priorities to position the Project for its next development phase by:Advancing the financing strategy by securing funding for Project priorities and progressing strategic financing discussions with potential partners;Completing the acquisition of, or access to, the remaining land surface rights required for full Project development;Strengthening the Project's regulatory foundation through the continuous advancement of permitting, further reducing development risk and demonstrating Project readiness; andMaximizing non-dilutive capital by actively pursuing grants and incentives available from the EU and the Czech state.Martina Blahova, President & CEO of Euro Manganese, commented:"The publication of these PEA results marks another important milestone for the Chvaletice Manganese Project. Our recent optimization work has delivered measurable improvements in recovery, confirming both the strength of our technical strategy and the reliability of our process. To enhance capital efficiency and align investment with market demand, we have adopted a phased construction approach that maximizes value while reducing execution risk. The addition of by-product revenue stream further incrementally strengthens the economics of the project."This disciplined approach, coupled with conservative product pricing assumptions, supports a robust project profile with a strong operating margin of 48%, underscoring the Project's ability to perform through market cycles. Despite the challenging market and pricing conditions, the PEA results demonstrate the strength and resilience of the Project. It provides a clear pathway to unlocking the full long-term value of the Chvaletice Manganese Project as demand accelerates for localized, traceable, and sustainably produced battery grade high purity manganese. We are built to perform in volatile markets, engineered for operational efficiency, and positioned to play a strategic role in securing resource independence and reducing vulnerability amid an increasingly complex global landscape."Rick Anthon, Chairman of Euro Manganese, commented:"As a Board, we are encouraged by the progress reflected in this PEA and confident the Chvaletice Manganese Project can deliver on these terms for its shareholders, customers and stakeholders. The team has advanced the Project with a clear focus on technical rigour, capital efficiency, and responsible development. The phased construction strategy and strengthened economic profile demonstrate a thoughtful approach to building a long-life asset that can scale with market demand."With no operating manganese mines in Europe and as the only integrated high purity manganese producer in Europe and North America, the Chvaletice Manganese Project is uniquely positioned to become a cornerstone of Europe's emerging battery materials supply chain. The Project's strategic relevance, combined with its strong environmental credentials and growing commercial traction, reinforces our confidence in its long-term value. We believe the foundations are now firmly in place for Chvaletice Manganese Project to move toward the next stage of development and deliver meaningful returns for shareholders."PEA SUMMARY AND ECONOMIC ANALYSISThe PEA was completed by Tetra Tech Canada Inc. ("Tetra Tech"). A NI 43-101 technical report on the PEA will be filed under the Company's profile on SEDAR+ within 45 days of this news release and made available on the Company's website. A JORC report will be lodged with the Australian Securities Exchange ("ASX") ASX shortly thereafter.The following summarizes the material assumptions used in, and the results of, the PEA, assuming a targeted start of production in 2032.The Czech corporate income tax rate is 21%. In addition to the royalty of CZK 2,308 per tonne of unit Mn produced, the Czech Republic has various payroll and other taxes to generate revenue.The Company has modeled the economics of this project conservatively from a tax perspective, with a full tax burden, based on Czech legislated tax rates.Investment incentives exist in the Czech Republic and the European Union for certain, qualified investments, including investment tax credits, grants, and accelerated depreciation.The Company is actively pursuing these non-dilutive funding opportunities, including investment tax credits, grants, and accelerated depreciation available under both Czech and EU frameworks.Sensitivity AnalysisA sensitivity analysis for the Chvaletice Manganese Project was carried out to determine the effects of key variables in relation to the post-tax NPV of $492 million at a real discount rate of 8%. The results of the sensitivity analysis are presented in Table 3 below.Initial and Sustaining Capital EstimatesCapital expenditure estimates have been prepared for both initial and sustaining capital. A projected summary timeline of scheduled capital costs is shown in Table 4.The expected initial capital expenditures (Table 4) for the Project, inclusive of capitalized operating startup costs, as estimated by Tetra Tech, as of Q1, 2026, are $627.5 million, including all development-related costs that will be incurred prior to the envisaged commencement of commercial operations. Capital costs incurred after startup are assigned to sustaining capital and are projected to be paid out of operating cash-flows (also see Table 5). Contingencies on initial capital expenditure have been added at appropriate percentages to each component of the Project, excluding capitalized operating costs, resulting in an overall contingency of $66.7 million or 15.5% of direct costs.The Project site is served by excellent existing infrastructure, including rail, highway, a gas pipeline, and water and is adjacent to an operating power plant. The proposed plant site is zoned for industrial use and is the site of the former process plant that produced the Chvaletice tailings.New and refurbished infrastructure that will be built to service the Project include a tailings excavation and handling facility: a south and north site connection utility bridge for transporting tailings slurry, return water pipes and the tube conveyor that returns a mixture of non-magnetic tailings and washed leach residue to the residue dry stacking area; a magnetic separation beneficiation plant; enclosed and winterized process plant buildings and various reagent storage facilities and product warehouse; an upgraded rail spur system with related loading/unloading facilities; an internal road network; an incoming electrical 400kV high voltage grid connection including rectifiers, transformers, GIS switchgear, and local distribution step-down transformers; a process equipment maintenance workshop; a mobile fleet maintenance workshop; spare part and maintenance supply warehouses; a comprehensive water management system, onsite laboratories; and general administrative offices.Operating Cost EstimateOnsite operating costs are expected to average $181.99 per tonne plant feed ($4.14 per kg Mn equivalent) with offsite operating costs estimated to average $31.73 per tonne plant feed ($0.72 per kg Mn equivalent), as shown in Table 5.Resource EstimateTetra Tech was engaged to oversee the planning and execution of sampling and assaying, to prepare the updated Resource Estimate for EMN's Chvaletice Manganese Project, to prepare the Technical Report in accordance with National Instrument 43-101 - Standards and Disclosures for Mineral Projects, and to prepare the independent JORC Code technical report in accordance with the Joint Ore Reserves Committee Australasian Code for Reporting of Exploration Results, Mineral Resources and Ore Reserves 2012 Edition ("JORC Code"). The 43-101 Technical Report, entitled "Technical Report and Mineral Resource Estimate for the Chvaletice Manganese Project, Chvaletice, Czech Republic", with an effective date of December 8, 2018 ("the Mineral Resource Estimate"), was filed on SEDAR on January 28, 2019. The corresponding JORC Code technical report with an effective date of December 8, 2018, was lodged on the ASX on February 6, 2019.No additional drilling or data collection pertaining to the technical disclosure of mineral inventory has been undertaken since the completion of the Mineral Resource Estimate, and the effective date for Mineral Resource Estimate is revised to April 27, 2026.The Project's combined Measured and Indicated Resources now amount to 26,960,000 tonnes, grading 7.33% total manganese (tMn) and 5.86% soluble manganese (sMn), as detailed in Table 6 below.PROCESSING FACILITIES DESCRIPTIONTailings Extraction, Residue Storage Facility and ReclamationIn the tailings extraction plan, the three tailings cells will be excavated in a counterclockwise sequence, starting with Cell #3, followed by Cells #1 and #2. Tailings will be extracted using shovel excavators and hauled by truck to an intermediate re-pulping and a covered storage station located between Cells #1 and #2. The storage station will create a 5-day material stockpile. Re-pulped tailings will be fed to the magnetic separation plant via a slurry pipeline on a continuous basis.A filtered blend of non-magnetic tailings and washed leach residue materials from the process plant will be conveyed using a tube conveyor to the storage station and placed and compacted in the Residue Storage Facility (RSF). The excavated area exposed after extraction of the existing tailings will be lined with a geomembrane liner. The RSF will be constructed in stages to suit residue storage requirements and progressively covered to limit the footprint of residue exposed to the air at any given time.RSF design features include a geomembrane lined bottom, perimeter surface water diversion and a contact water collection system that is integrated with the overall site water management system. Dust management includes the implementation of modern dust suppression methods on open faces, interim stack surfaces and haul roads, as required.Progressive reclamation will be undertaken as an integrated part of the residue stacking procedure. The filtered residue cover will consist of a low permeability soil and/or geomembrane cover to inhibit erosion and infiltration, and a growth layer to support vegetation growth.The site is expected to be fully reclaimed and brought back into a productive community to be established in consultation with local communities, regulators and national government agencies. The RSF will be monitored during the post-closure period for geotechnical and environmental performance.High Purity Manganese Products Production FacilityThe processing facilities, including ancillary facilities, for HPMSM production from the CMP tailings were designed by Beijing General Research Institute for Mining ("BGRIMM") together with EMN and Tetra Tech, based on the comprehensive metallurgical test results conducted during the previous PEA and validated through bench scale tests during the feasibility study. Additional metallurgical tests to recover manganese from anode slimes from electrowinning circuit were also conducted to support this PEA.The study was based on the design work completed for the 2022 Feasibility Study which included process circuit and process equipment optimization. Key equipment items were sized and selected based on the FS design by upgrading HPMSM circuit from the nominal capacity of 100,000 t/a to 150,000 t/a. In addition, two additional circuits, one for manganese recovery from anode slimes produced from the electrowinning circuit using reductive leaching and one for sodium and potassium removal from the HPMSM crystallization circuit by incorporating a high-temperature crystallization bypass system. One additional circuit to convert the magnesium carbonate from waste to a saleable by-product is incorporated into the magnesium removal circuit.The CMP process plant has been designed for a nominal nameplate production capacity of 150,000 tonnes per annum of HPMSM by processing approximately 1.1 million tonnes of the historical tailings per year.HPMSM is produced by converting HPEMM flakes produced by electrowinning process without the use of selenium and chromium. This product is expected to best meet the high purity manganese market demand anticipated in current and future battery formulations.The CMP HPMSM product is designed to contain no less than 99.9% high purity manganese sulfate monohydrate and a minimum of 32.34% manganese and will be sold in powder form, produced without the use of fluorine.The dried HPMSM powder product will be packed prior to being shipped in trucks or containers to customers .The process includes following unit circuits:High-intensity wet magnetic separation circuit, upgrading the excavated tailings manganese grade to approximately 15% tMn for acid leaching.Magnetic concentrate sulfuric acid leaching, neutralization to remove impurities and solid-liquid separation.Pregnant leach solution deep purification to further remove heavy metals.Manganese electrowinning to produce high purity HPEMM (high-purity electrolytic manganese metal) flakes using a selenium free process.A magnesium removal process circuit to ensure efficient electrowinning operations and high-quality product and magnesium carbonate produced as a by-product.HPEMM dissolution, solution purification and HPMSM crystallization and drying to produce battery-grade HPMSM for sale.Other supporting circuits, such as ammonium recovery system, water management systems, steam generation. The proposed process flow sheet is illustrated in Figure 1 below.Figure 1: Updated Simplified Process FlowsheetTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/11453/297390_4c2a5f3814e549ad_001full.jpgENVIRONMENTAL IMPACTS, PERMITTING AND COMMUNITY ENGAGEMENTEnvironmental impacts are monitored over the long term as part of the project. The ESIA process was conducted in two phases, supplemented by several expert studies and on-site monitoring. The result of the ESIA process, which involved participation from relevant authorities and the public, is the positive Environmental and Social Binding Statement, which was issued by the Ministry of Environment in March 2024. The ESIA permit is a crucial permit demonstrating that the assessed impacts on individual environmental components and the social sphere are acceptable and that the project is feasible.The assessment results show that the implementation of the project will not worsen existing environmental conditions and will not have negative social impacts. Furthermore, the realization of the project will reduce the identified contamination of groundwater and surface water in the tailings and its vicinity, where the source of the pollution is demonstrably deposited material. As the deposit is of anthropogenic origin and the mined material is a waste-product, this constitutes the reuse or recycling of waste, aligning with the principles of the circular economy. The aim of remediation and reclamation is to create a near-natural area with high biodiversity and stability, which will be used for recreational and sports activities.The ESIA process is followed by a subsequent permitting process when a significant portion of the permits had already been obtained, such as the Permit for the location of the processing plant, the Permit for the location of the rail spur, Product registration under the EU's REACH Regulation, and other permits related to auxiliary activities (utility relocations, grid connection, and others). Another key permit is the Determination of the Mining Lease Permit, which was granted to MANGAN Chvaletice, s.r.o on January 23, 2025; this is another crucial permit which authorizes the company to conduct mining activities. In the following steps, the company will undergo the permitting process stipulated by the Building Act, followed by the final operating permit.In 2026, the Company will continue to advance the permitting process under the Building Act, targeting completion of the final operating permit pathway in line with the feasibility study timeline. Each permitting milestone achieved further reduces Project risk and reinforces the Company's readiness to move into the next phase of development.Key Highlights of the Social Commitment:Significant Economic Catalyst: The Project will act as a primary economic driver in the Pardubice Region, creating 800-1,000 jobs during construction and providing stable, long-term employment for approximately 400 direct staff during operations, with a strong 85% local hiring commitment.Commitment to Transparency: The Project has established a robust engagement framework, including a dedicated public information center in Chvaletice and dedicated digital platforms (project-specific website and online grievance tools).Validated Social Acceptance: On March 27, 2024, the Czech Ministry of the Environment issued a favorable binding ESIA opinion, confirming that the Project meets the highest environmental and social standards. The Project currently faces no material barriers to acceptance, reflecting a strong Social License to Operate.BENEFITS OF PEA AND NEXT STEPSThe PEA enabled the Company to optimize inputs based on current pricing, establishing the possibility for a two-stage construction strategy. This phased approach has the potential to allow for further optimization in phase two, lower upfront capital requirements, and enhance project economics by aligning investment with cash flow. The Company plans to explore this and other avenues to advance the Chvaletice Manganese Project further towards feasibility study, with targeted completion in H1 2027.The Company will also continue to monitor high purity manganese markets and strategic sectors to which it contributes, including energy transition, grid-scale energy storage, e-mobility and aerospace and defence technologies. The Company will continue to engage with potential customers to secure additional offtake term sheets, pursue offtake agreements, and continue product testing.In addition, during 2026, the Company is focused on the following key priorities to position the Project for its next development phase by:Advancing the financing strategy by securing funding for Project priorities and progressing strategic financing discussions with potential partners;Completing the acquisition of, or access to, the remaining land surface rights required for full Project development;Strengthening the Project's regulatory foundation through the continuous advancement of permitting, further reducing development risk and demonstrating Project readiness; andMaximizing non-dilutive capital by actively pursuing grants and incentives available from the EU and the Czech state.Competent and Qualified Person StatementAll production targets for the Chvaletice Manganese Project referred to in this news release are underpinned by estimated Measured and Indicated Mineral Resources prepared by Competent Persons and Qualified Persons in accordance with the requirements of the JORC Code and NI 43 - 101, respectively. Additionally, the scientific and technical information included in this news release, is based upon information prepared, verified, and approved by Mr. James Barr, P. Geo, Senior Geologist, Mr. Jianhui (John) Huang, Ph.D., P. Eng., Senior Metallurgical Engineer, Mr. Hassan Ghaffari, P.Eng, M.A.Sc., Senior Process Engineer, Mr. Chris Johns, P.Eng, Senior Geotechnical Engineer, and Mrs. Maurie Marks, P.Eng, Senior Mining Engineer, all with Tetra Tech. Mr. Barr, Mrs. Marks, Mr. Ghaffari, Mr. Johns, Mr. Hasanloo and Mr. Huang are consultants to, and independent of, EMN within the meaning of NI 43-101, and have sufficient experience in the field of activity being reported to qualify as Competent Persons as defined in the JORC Code, and are Qualified Persons, as defined in NI 43-101. Mr. Barr is responsible for the Mineral Resource Estimate, Mr. Huang is responsible for the metallurgical test work results, process engineering, operating cost and capital cost estimates, environmental studies, permitting, and social or community impact. Mr. Ghaffari is responsible for infrastructure, Mrs. Marks is responsible for mining and financial analysis, Mr. Johns is responsible for design of the residue storage facility. Mr. Barr visited the property during the 2017 drilling program and again during the 2018 drilling campaign, on July 30-31st, 2018, during which time he observed the drilling, sample collection and preparation, sample logging and sample storage facilities. Mr. Huang visited the Project site on February 5, 2018 and May 3, 2022, as well as visited the Changsha Research Institute of Mining and Metallurgy Co. ("CRIMM") laboratory and pilot plant facility five times between January 20, 2017 and September 20, 2018 to witness sample preparation and test/assay facilities and to discuss the test program and results with CRIMM's technical team. Mr. Huang also visited the SGS Minerals Services (SGS) laboratory on June 29, 2017, and oversaw the bench scale validation test work completed by BGRIMM. Mrs. Marks, Mr. Johns and Mr. Ghaffari also visited the project site on May 3, 2022. Barr, Huang, Ghaffari, Johns and Marks have no economic or financial interest in the Company and consent to the inclusion in this news release of the matters based on their information in the form and context in which it appears.In addition, technical information concerning the Chvaletice Manganese Project is reviewed by Dr. David Dreisinger, P. Eng, a Qualified Person under NI 43-101. Dr. Dreisinger has reviewed and approved the information in this news release for which he is responsible and has consented to the inclusion of the matters in this news release based on the information in the form and context in which it appears.Cautionary StatementThe PEA is a high-level review of potential, is preliminary in nature, and there is no certainty that the economics in the PEA will be realized. The PEA results are not equivalent to, and should not be construed as, a Pre-Feasibility Study or Feasibility Study. Accordingly, investors are reminded that the PEA is considered preliminary in nature and includes estimated costs that are subject to an approximate margin error of plus or minus 35%. Mineral Resources that are not Mineral Reserves do not have demonstrated economic viability, and there is no guarantee the Project's resources will eventually be classified as reserves.The projected process plant design, potential production profile and project plan are conceptual in nature and additional technical studies will need to be completed in order to fully assess their viability. There is no certainty that a potential production decision will be made, or that a commercial operation will be achieved.A sensitivity analysis for the Project was carried out to determine the effects of key variables in relation to the post-tax NPV of US$492 million using a real discount rate of 8%. The results of the sensitivity analysis are presented in Table 3 of this announcement. Additional sensitivities from changes in capital and operating costs, recoveries, and metal prices are also included in Table 3.The PEA is also based on the material assumptions outlined in this announcement. These include assumptions about the availability of funding. While EMN considers all of the material assumptions to be based on reasonable grounds, including those related to funding, there is no certainty that they will prove to be correct or that the range of outcomes indicated by the PEA can be achieved.To achieve the range of outcomes indicated in the PEA, funding in the order of approximately US$670.9 million is assumed to be required for initial capital expenditures and working capital. It is anticipated that funding will be sourced through a combination of equity and debt, and possibly other means; however, given that the PEA is considered preliminary in nature, the Company expects to finalize its financing strategy for the Project in conjunction with, or after, the completion of the feasibility study.Investors should note that there is no certainty that EMN will be able to raise that amount of funding when needed. It is also likely that such funding may only be available on terms that may be dilutive to or otherwise affect the fundamental value of EMN's existing shares. It is also possible that the Company could pursue other 'value realisation' strategies such as a sale, partial sale or joint venture of the Project. If such strategies are pursued, it could materially reduce EMN's proportionate ownership of the Project. Given the uncertainties involved, investors should not make any investment decisions based solely on the results of the PEA.Euro Manganese is dual listed on the TSX-V and the ASX. Neither TSX Venture Exchange nor its Regulation Services Provider (as defined by TSXV policies) or the ASX accepts responsibility for the adequacy or accuracy of this release.Authorized for release by the President and CEO of Euro Manganese Inc.Martina BlahovaPresident and CEO+1 (604) 681-1010info@mn25.caJane Morgan ManagementJane MorganInvestor and Media Relations - Australia+61 (0) 405 555 618jm@janemorganmanagement.com.auLodeRock AdvisorsNeil WeberInvestor and Media Relations - North America+1 (647) 222-0574neil.weber@loderockadvisors.com About Euro ManganeseEuro Manganese Inc. (TSXV: EMN) (ASX: EMN) (FSE: E060) is a battery materials company developing the Chvaletice Manganese Project in the Czech Republic, Europe's only near-term source of high-purity manganese, a critical ingredient in next-generation electric vehicles, energy storage batteries and defence applications.The Chvaletice Manganese Project aims to reprocess historic mine tailings to produce high-purity electrolytic manganese metal (HPEMM), and high-purity manganese sulphate monohydrate (HPMSM), establishing a fully traceable, low-carbon supply chain within the European Union.Euro Manganese is positioned to become Europe's first domestic producer of high-purity manganese, meeting the rising demand for sustainable, strategic battery materials while advancing Europe's clean-energy and supply-chain independence goals.Forward-Looking StatementsCertain statements in this news release constitute "forward-looking statements" or "forward-looking information" within the meaning of applicable securities laws. Such statements and information involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance, or achievements of the Company, its Chvaletice Project, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. Such statements can be identified by the use of words such as "may", "would", "could", "will", "intend", "expect", "believe", "plan", "anticipate", "estimate", "scheduled", "forecast", "predict" and other similar terminology, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved.Readers are cautioned not to place undue reliance on forward-looking information or statements. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements and, even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, the Company.Forward looking information or statements include all of the results of the PEA, including estimates of internal rates of return (including any pre-tax and after-tax internal rates of return, payback periods, net present values, future production, estimates of cash cost, assumed prices for HPEMM and HPMSM and by-products, proposed extraction plans and methods, operating life estimates, cash flow forecasts, metal recoveries and estimates of capital and operating costs. Forward looking statements also include the possibility for a two-stage construction strategy, and the potential to allow for further optimization of the Project in phase two, with lower upfront capital requirements, and to enhance project economics by aligning investment with cash flow. The Company has based its assumptions and analysis on certain factors that are inherently uncertain, including (i) the adequacy of infrastructure; (ii) the ability to develop adequate processing capacity; (iii) the price of HPEMM and HPMSM and by-products; (iv) the availability of equipment and facilities necessary to complete development; (v) the size of future processing plants and future tailings extraction rates; (vi) the cost of consumables and extraction and processing equipment; (vii) unforeseen technological and engineering problems; (viii) currency fluctuations; (ix) changes in laws or regulations; (x) the availability and productivity of skilled labour; and (xi) the regulation of the mining industry by various governmental agencies.Forward-looking statements also include statements regarding the Company's strategy for its Chvaletice Project, ability to access high purity manganese markets and strategic sectors to which it contributes, including energy transition, grid-scale energy storage, e-mobility and aerospace and defence technologies and sell its products, the ability to complete a feasibility study in 2027, and the Company's ability to navigate current market conditions. In addition, forward-looking statements include statements regarding the Company's next steps including: advancing financing efforts; seeking strategic partners, finalizing product testing, and negotiating offtake agreements with customers; Securing remaining land access; progressing key permits; and pursuing government funding.All forward-looking statements are made based on the Company's current beliefs including various assumptions made by the Company, including that the Chvaletice Project will be developed and operate as planned, the results of the PEA are reliable, that the Company will have sufficient financing to continue operations, and that the Company will be able to meet the conditions of its secured financing. Factors that could cause actual results or events to differ materially from current expectations include, among other things: results from the PEA are not accurate; insufficient working capital; inability to meet the conditions of its secured financing, risks due to granting security, lack of availability of financing for developing and advancing the Chvaletice Project; no available government funding or incentives; the potential for unknown or unexpected events to cause contractual conditions to not be satisfied; developments in electric vehicle battery markets and chemistries; risks related to fluctuations in currency exchange rates; and changes in laws or regulations by various governmental agencies. For a further discussion of risks relevant to the Company, see "Risk Factors" in the Company's annual information form for the year ended September 30, 2025, available on the Company's SEDAR+ profile at www.sedarplus.ca.Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release and are expressly qualified in their entirety by this cautionary statement. Subject to applicable securities laws, the Company does not assume any obligation to update or revise the forward-looking statements contained herein to reflect events or circumstances occurring after the date of this news release. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297390 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年5月14日 - (亚太商讯 via SeaPRwire.com) - 随着搜索日益由人工智能主导并呈现“零点击”趋势，品牌需要制定新策略，以塑造其在搜索结果中的呈现方式，而不仅仅是链接展示。亚太地区已成为全球人工智能搜索应用的领导者，78%的用户表示每周都会使用该功能。在用户访问网站之前，人工智能搜索体验正日益影响着品牌的发现与考量。为此，全球全渠道媒体代理机构Assembly今日宣布在亚太地区推出Stagwell Search+——这一全新系统旨在帮助品牌理解并影响其在AI驱动的搜索环境中的呈现方式。此次发布标志着搜索营销已从单纯的独立渠道转变为生态系统的一部分。Stagwell Search+覆盖付费、自有、 earned（ earned media 指通过优质内容自然获得的媒体曝光）及共享媒体的完整生态系统，在该生态中，AI生成的答案决定了品牌的可见度与表现。这一转变在亚太地区尤为复杂。该地区的大型语言模型格局分散，涉及多种语言和文化背景，导致品牌可见性不一致。一个品牌在某个模型中可能显得权威，但在另一个模型中却可能隐形或被误解，这给营销人员带来了新的、且在很大程度上无法衡量的风险。Stagwell Search+由Assembly与emberos合作开发，搭载了业界首个面向AI搜索的代理操作系统。该平台持续监测品牌在不同模型和语言中的呈现情况，并统筹协调及衡量内容、媒体和数字渠道各项举措带来的提升效果，从而改善品牌可见度。系统并非直接将变更自动化推送至各平台，而是通过AI代理引导人类决策——帮助团队采取精准、战略性的行动，同时保障品牌体验的质量与完整性。Stagwell Search+ 目前已集成 OpenAI、Gemini、Perplexity、Grok 和 Anthropic 等全球领先的 AI 模型，并计划于今年晚些时候与 DeepSeek 等区域性平台进行进一步集成。“AI 已经在没有营销人员参与的情况下做出品牌决策——而在亚太地区，语言和文化的复杂性进一步加剧了这一挑战，”亚太区体验与激活副总裁 Yi En Chye 表示。“成功的定义不再是排名或点击量，而是品牌能否赢得‘提示词份额’。Stagwell Search+为品牌提供了在这个新环境中竞争所需的可视性和控制力。”关于 AssemblyAssembly 是一家全球全渠道代理机构，致力于为寻求更现代品牌建设方法的品牌提供服务。依托 Stagwell 网络，我们真正汇聚了数据、人才与技术，旨在自下而上（而非自上而下）释放更智能、更快速、更卓越的成果。我们充满好奇心、善于协作且勇于变革，是一支由建设者组成的团队，坚信体验越出色，表现越卓越。我们不认为品牌与绩效是二选一的关系。对我们而言，二者永远相辅相成。我们标志中的“+/”符号，即“ORAD”，正是这种思维方式的体现。它象征着我们的思维方式、构建方式以及在整个营销漏斗中交付成果的方式。Assembly 的根基建立在三个核心要素之上：专为实现目标而打造的 STAGE 体验引擎、由其驱动的战略产品——品牌绩效规划（BPP），以及为速度、深度和现代营销需求量身定制的组织架构。三者协同运作，使我们能够打造更卓越的品牌体验，重新定义品牌在数据、技术、媒体、创意和商业领域中的连接、互动与增长方式。Assembly在全球44个办事处拥有超过3,000名专家，提供全漏斗解决方案，助力全球最具雄心的品牌实现卓越表现。了解更多信息，请访问 assemblyglobal.com。关于 StagwellStagwell 是一家通过人工智能重塑营销格局的全球挑战者网络。我们为全球最具雄心的品牌提供规模化的创意营销成效，将引领文化潮流的创意与尖端技术相结合，实现营销艺术与科学的和谐统一。在企业家的领导下，我们遍布 45 多个国家的专家团队秉持共同目标：为客户提升营销效果并改善业务成果。欢迎访问 www.stagwellglobal.com 加入我们。媒体联系Kelvin Lee亚太区市场营销总监Kelvin.lee@assemblyglobal.com 来源：Assembly Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, May 14, 2026 - (ACN Newswire via SeaPRwire.com) - As search becomes increasingly AI-led and zero-click, brands need new strategies to shape how they appear in answers, not just in links. APAC has emerged as a global leader in AI Search adoption, with 78% of users reporting weekly usage. Increasingly, AI Search Experiences shape brand discovery and consideration before users ever visit a website.In response, global omnichannel media agency Assembly today announced the rollout of Stagwell Search+ in APAC - a new system designed to help brands understand and influence how they are represented across AI-driven search environments.The launch marks a fundamental shift away from treating search as a standalone channel. Instead, Stagwell Search+ operates across a full ecosystem of paid, owned, earned, and shared media, where AI-generated answers determine visibility and performance. This shift is especially complex in APAC, where a fragmented landscape of large language models, spanning multiple languages and cultural contexts, creates inconsistent brand visibility. A brand may appear authoritative in one model while remaining invisible or misrepresented in another, introducing a new and largely unmeasured risk for marketers.Built by Assembly in partnership with emberos, Stagwell Search+ is powered by the industry's first agentic operating system for AI search. The platform continuously monitors how brands appear across models and languages and orchestrates & measures the lift from actions across content, media, and digital channels to improve visibility. Rather than automating changes directly into platforms, the system is designed to guide human decision-making with AI agents - helping teams take precise, strategic action while protecting the quality and integrity of brand experiences.Stagwell Search+ is currently integrated with leading global models from OpenAI, Gemini, Perplexity, Grok, and Anthropic with additional integrations across regional platforms such as DeepSeek planned for later this year."AI is already making brand decisions without marketers in the room - and in APAC, that challenge is amplified by language and cultural complexity," said Yi En Chye, VP of Experience and Activation, APAC. "Success is no longer defined by rankings or clicks, but by a brand's ability to secure share of prompt. Stagwell Search+ gives brands the visibility and control they need to compete in this new environment."ABOUT ASSEMBLYAssembly is a global omnichannel agency built for brands that want a more modern approach to building brands that perform. Backed by the Stagwell network, we are a literal assembly of data, talent, and technology built to unlock smarter, faster, and better-performing outcomes from the bottom up -not the top down. Curious, collaborative, and driven by change, we are an agency of builders who believe the better the experience, the better the performance. We don't see brand and performance as an either/or. For us, it's always both. The + symbol in our logo, known as the ORAD, represents this mindset. It's a mark of how we think, how we build, and how we deliver results across the full funnel. Assembly's foundation is built on three core elements: our purpose-built STAGE Experience Engine, the strategic product it powers-Brand Performance Planning (BPP) - and an organizational design built for speed, depth, and the demands of modern marketing. Together, they enable us to build better brand experiences that reimagine how brands connect, engage, and grow across data, tech, media, creative and commerce. With over 3,000 experts in 44 offices worldwide, Assembly delivers full-funnel solutions that help the world's most ambitious brands perform. Learn more at assemblyglobal.com.ABOUT STAGWELLStagwell is the global challenger network transforming marketing through AI. We deliver scaled creative performance for the world's most ambitious brands, connecting culture-moving creativity with leading-edge technology to harmonize the art and science of marketing. Led by entrepreneurs, our specialists in 45+ countries are unified under a single purpose: to drive effectiveness and improve business results for our clients. Join us at www.stagwellglobal.com.MEDIA CONTACTKelvin LeeMarketing Director, APACKelvin.lee@assemblyglobal.comSOURCE: Assembly Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

NEW YORK, USA AND ABU DHABI, UAE, May 13, 2026 - (ACN Newswire via SeaPRwire.com) - Sherlocq, the first AI-native regulatory intelligence platform for global financial services, today announced its public launch. Designed for compliance officers, lawyers, risk professionals, and regulators who operate at the intersection of law, governance, and institutional accountability, Sherlocq delivers regulatory intelligence that is precise, traceable, and usable at institutional scale.The launch marks the emergence of a new category in enterprise AI: regulatory intelligence, a vertical distinct from generic AI assistants, conventional regtech monitoring tools, and document management platforms. Sherlocq has been built from the ground up to meet the security, privacy, and domain standards that regulated institutions require, and which no general-purpose AI platform has been designed to deliver.THE PROBLEMFinancial institutions, law firms, regulators, and consultants collectively spend over $300 billion every year on regulatory compliance. More than ten million professionals carry the weight of that complexity daily, tracking regulatory changes across dozens of jurisdictions, reviewing thousands of documents, and making high-stakes decisions that can determine the fate of institutions and individuals alike.Until now, the tools available have been fundamentally inadequate: monitoring without interpretation, alerts without answers, search without synthesis. Regulatory research has remained a largely manual process for decades. Vertical AI has already demonstrated category-defining value in adjacent domains. Regulatory intelligence represents a larger, more global, and more complex opportunity.Sherlocq changes that.THE PLATFORMAt launch, Sherlocq covers the regulatory output of governments, supervisory authorities, and enforcement bodies across 30+ jurisdictions, including the US, UK, UAE, Singapore, and Hong Kong. It ingests, structures, and indexes this information continuously, so when a compliance officer, lawyer, or risk professional asks a question, Sherlocq returns a precise, sourced, and traceable answer in seconds. Research that previously required hours of manual work across multiple sources is completed in under a minute.The platform launches with three live capabilities:Regulatory Research and Analysis - Multi-jurisdiction research, cross-border regulatory comparison, compliance framework analysis, and obligation mapping across the full spectrum of financial services regulation, covering all major regulated financial centres.Document Intelligence - Structured review, gap assessment, benchmarking, and policy analysis against applicable regulatory standards, available on the native Sherlocq platform.Sanctions Intelligence - Real-time, multi-regime sanctions research across OFAC, OFSI, EU, UAE, and 320+ data sources in a single query, with full source traceability. The first AI-native platform to deliver this level of depth and auditability across multiple sanctions regimes simultaneously.Sherlocq is available on web, iOS, and Android, for individual professionals and enterprise organisations. AI connectors are live for Claude and ChatGPT, enabling regulatory research to be accessed directly within the tools professionals already use. Microsoft Copilot and Google Gemini integrations follow shortly.Sherlocq is certified to ISO 27001 and ISO 27701 standards, meeting the security and data privacy requirements of regulated financial institutions globally.FOUNDER'S STATEMENT"I have spent my career sitting across the table from regulators, leading investigations at the highest levels, and advising institutions in the most consequential moments of their existence. In every one of those engagements, the same problem recurred: brilliant professionals, at world-class institutions, spending most of their time on research and cross-referencing that should have been automated years ago. Not because the technology did not exist. Because no one had built it with the rigour, the domain depth, and the institutional trust that this work demands. That is what we built. Sherlocq is not a general AI tool adapted for compliance. It is the intelligence infrastructure that this industry has always needed and never had," said Bhavin Shah, Founder and Chief Executive Officer, Sherlocq.ABOUT THE FOUNDERBhavin Shah is a globally recognised regulatory and compliance leader with over twenty years of experience advising sovereigns, regulators, boards, and financial institutions across their most complex and politically sensitive challenges. His career spans multi-jurisdiction investigations, AML and financial crime reform, regulatory negotiations, crisis management, and governance advisory across the US, UK, Middle East, and Asia Pacific. He has advised some of the world's most consequential regulatory reform processes and financial institutions at moments of institutional stress, enforcement risk, and strategic transformation.Shah is a World Economic Forum Young Global Leader (2020), a board member of the D2A2 digital assets and AI policy forum, and holds executive education credentials from Harvard Business School and Harvard Kennedy School. He serves as an independent non-executive director on the boards of regulated financial institutions, giving him direct and ongoing insight into the governance, compliance, and regulatory pressures that Sherlocq is designed to address.INDUSTRY VOICES"Regulatory complexity has been accelerating for years and this is only compounding with the recent trends toward fragmentation around the globe. The tools available to compliance professionals have not kept pace. Sherlocq addresses that gap in a way that is substantive, not superficial. What distinguishes this platform is that it has been built with a genuine understanding of how regulated institutions work and what they actually need to be more effective and more efficient. The depth, the traceability, and the institutional-grade approach reflect the kind of rigour that regulators and boards rightly expect. I am proud to support Bhavin and the Sherlocq team as they bring this important product to market," said Bryan Stirewalt, Former Chief Executive, Dubai Financial Services Authority; Former National Bank Examiner, Office of the Comptroller of the Currency; Board Advisor, Sherlocq."Running a banking group across more than 35 markets meant living with regulatory complexity as a daily operational reality. Our teams were talented and diligent but the tools available forced them into a process that was slow, fragmented and heavily manual. Sherlocq solves that problem. It gives compliance and legal professionals the structured multi-jurisdictional intelligence that I would have wanted for my team. This is the platform the industry has always needed,” said Arnold Ekpe, Former Group Chief Executive Officer, Ecobank Group; Board Advisor, Sherlocq.ABOUT SHERLOCQSherlocq Inc. is a US-incorporated AI technology company (Delaware) with principal offices in New York and Abu Dhabi, UAE, and the creator of the first AI-native regulatory intelligence platform purpose-built for global financial services. The company has completed a pre-seed financing round backed by investors across the US, UAE, and Europe. Designed for compliance officers, lawyers, risk professionals, regulators, and governance teams, the platform delivers multi-jurisdiction regulatory research, document intelligence, and sanctions intelligence, with workflow automation and deeper enterprise capabilities on the near-term roadmap. Sherlocq is certified to ISO 27001 and ISO 27701 standards and is available globally on web, iOS, and Android. Financial institutions, law firms, and professional services organisations seeking enterprise access are invited to contact hello@sherlocq.com. sherlocq.com | sherlocq.ai | hello@sherlocq.com MEDIA CONTACTFor media enquiries, interview requests with Bhavin Shah, or access to additional materials including product demonstrations, founder biography, and platform assets:Press contact: press@sherlocq.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

BILLUND, DENMARK, May 13, 2026 - (ACN Newswire via SeaPRwire.com) - At the LEGO Foundation's annual meeting, the Board of Directors elected Agnete Kirk Kristiansen as Chair of the Board. As fourth generation member of the Kirk Kristiansen family, owners of the LEGO Group, she becomes only the fifth Chair of the Foundation since it was founded in 1986.Agnete Kirk Kristiansen has served as Deputy Chair of the LEGO Foundation since 2023 and replaces her brother Thomas Kirk Kristiansen who steps down to assume the position of Deputy Chair. In addition to her role at the LEGO Foundation, Agnete Kirk Kristiansen also serves as Deputy Chair of KIRKBI A/S, the family-owned holding and investment company that owns 75% of the LEGO Group.As ascending Chair, Agnete Kirk Kristiansen highlighted the role of the LEGO Foundation in building a brighter tomorrow for children around the world:I am truly honored to step into the role as Chair of the LEGO Foundation and to continue our important work for children. The foundation holds a very special place in our family and has done so ever since it was established more than 40 years ago. A deep sense of responsibility to make a positive difference for children runs through our family and I strongly believe that every child should have the opportunity to thrive and grow. I am proud to contribute to this mission and help carry it forward.The change in chair takes place the year after Agnete stepped into the role as chair of non-profit foundation Ole Kirk's Fond. With the transition, the fourth generation of the owner family is broadening its engagement and commitment to active ownership.Descending Chair Thomas Kirk Kristiansen said:It has been a privilege to chair the LEGO Foundation for the past 10 years, and I am very happy to now pass on the role to Agnete. She is deeply committed to the LEGO Foundation mission, and I know she will do her utmost to further the cause of securing a childhood for all. During her tenure as Deputy Chair, she has played an integral part in shaping the foundation's current strategy and as she steps into the role as Chair, we further widen the active ownership and engagement from the family across the LEGO ecosystem.Thomas Kirk Kristiansen has served as Chair of the LEGO Foundation since 2016 and in that period the foundation has committed grants of more than DKK 15 billion (EUR 2 billion) through partner organisations across the globe to improve children's outcomes.For 40 years, the LEGO Foundation has been focused on giving back and building a better world for children. We are very mindful of the trust families and communities place in us, and it is not a responsibility we take lightly. Even in the most challenging settings, the foundation can help put a smile on a child's face, lift up learners of all abilities and change life paths. We do so with the utmost sensitivity and responsibility, said Agnete Kirk Kristiansen.In addition to safeguarding the continued development and success of the LEGO Group as part-owner, the LEGO Foundation pursues its philanthropic mission to support initiatives within education, research, and child development through funding of and close collaboration with organisations such as Brac, IRC, UNICEF, Save the Children, Norwegian Refugee Council and others.Further changes to the LEGO Foundation BoardIn addition to Agnete and Thomas Kirk Kristiansen changing roles as Chair and Deputy Chair, the LEGO Foundation Board of Directors at its May meeting also elected as member of the Board Ingrid Stange, who brings a wealth of experience in philanthropy, education and non-profit leadership. Further, both Jørgen Vig Knudstorp, former CEO of the LEGO Group, and El Hadji Amadou Gueye Sy (As), former Secretary-General of the International Federation of Red Cross and Red Crescent Societies, left the Board after 16 and four years of service respectively to the LEGO Foundation.Thomas Kirk Kristiansen thanked the two departing Board members for their long-standing commitment to the foundation:We look very much forward to welcoming Ingrid, who brings highly complementary expertise to the board. At the same time, I thank As for bringing invaluable insights and experience to help shape our work.I would also like to extend my sincerest gratitude to Jørgen for his unwavering dedication to the foundation. During his extensive tenure, Jørgen has been instrumental in defining our vision and strategy while never losing sight of the children we are here to serve.Additionally, Malou Aamund, who has served on the Board since 2021, stepped into the role of Second Deputy Chair of the Foundation.Biography: Agnete Kirk KristiansenLEGO Foundation2026 - Chair of the Board of Directors2023 - 2026 Second Deputy Chair of the Board of DirectorsFrom 2008 Member of the Board of DirectorsKIRKBI A/S2024 - Deputy Chair of the BoardCentre for ADHD+, Aarhus, DenmarkFounderOle Kirk's Fond2025 - Chair of the BoardDegreePsychology, Aarhus University, 2010Additional roles, present and past:Executive Manager, KIRK83 Holding ApSMember of the Advisory Board, RucaRepresentative of the fourth generation of the LEGO owner familyExtensive experience in family-owned companies, long-term stewardship and board workLEGO Foundation Board of DirectorsAgnete Kirk Kristiansen - ChairThomas Kirk Kristiansen - First Deputy ChairMalou Aamund - Second Deputy ChairHilary Pennington - Member of the BoardIngrid Stange - Member of the BoardLEGO Foundation Board of Directors Chairs1986 - 1993: Gotfred Kirk Kristiansen (2nd-generation LEGO owner)1993 - 2000: Bent Skov2000 - 2016: Kjeld Kirk Kristiansen (3rd-generation LEGO owner)2016 - 2026: Thomas Kirk Kristiansen (4th-generation LEGO owner)2026 - Agnete Kirk Kristiansen (4th-generation LEGO owner)About LEGO Fonden:The LEGO Foundation is a Danish corporate foundation entrusted with 25 % ownership of the LEGO Group. The Foundation works with partners around the world to support children's needs and champion the dignity of childhood. Through both philanthropic donations and impact investments the Foundation exists to build the conditions and create the space for every child, everywhere, to thrive and grow. More information about the LEGO Foundation can be found at: https://www.legofoundation.com/Contact information:Mads Hvitved Grandmads.hvitved.grand@legofoundation.comSOURCE: LEGO Fonden Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

重点：· 根据第三方行业报告，随着医疗服务提供者持续向价值导向型和居家护理模式转型，美国远程患者监测（RPM）市场目前规模已达140亿美元，预计到2030年将达到约290亿美元，复合年增长率（CAGR）为12.6%¹· 通过其MSO基础设施，在多家医疗机构启动了试点项目，重点关注慢性病管理（CCM）和远程患者监测（RPM）· 截至目前，通过该试点基础设施已产生约1,500余份理赔，且扩展路线图旨在覆盖更多医疗服务提供者· Wellgistics药房网络拥有6,500多家独立药房，可为患者参与和护理协调计划提供支持· 参与该计划的药剂师有望获得新的临床服务收入机会佛罗里达州坦帕市, 2026年5月13日 - (亚太商讯 via SeaPRwire.com) - 领先的医疗科技与药品分销公司 Wellgistics Health, Inc.（纳斯达克代码：WGRX）（以下简称“Wellgistics”或“公司”）今日宣布，将与 Kare PharmTech 和 Kare Clinicals 开展试点合作，整合其管理服务组织（MSO）基础设施，以支持参与该计划的医疗机构开展慢性病管理（“CCM”）和远程患者监测（“RPM”）服务。据第三方行业报告显示，随着医疗服务提供者持续向价值导向型和居家护理模式转型，美国远程患者监测市场目前规模为140亿美元，预计到2030年将达到约290亿美元，复合年增长率（CAGR）为12.6%。¹该试点项目目前涵盖多家医疗机构，由 Kare Clinicals MSO 代表参与的医疗机构及服务提供方负责账单处理。该计划旨在通过可扩展的运营流程和技术驱动的工作流，支持患者参与、护理协调及纵向监测项目。所有慢性病管理（CCM）和远程患者监测（RPM）服务均应由持有相应执照的医疗服务提供方及参与实体，根据适用的联邦和州医疗保健法律、报销要求以及支付方项目规则提供并进行结算。双方公司表示，试点基础设施已产生1,500多份索赔，并计划以此为基础，逐步扩大服务范围，未来将覆盖更多医疗服务提供者。作为合作的一部分，Wellgistics Health计划利用其覆盖6,500多家独立药房的网络，协助识别并支持可能从CCM和RPM服务中获益的符合条件患者。Wellgistics药房网络内的参与药房还可能有机会参与与该项目相关的临床参与计划。Wellgistics Health, Inc.总裁兼首席执行官Prashant Patel表示：“我们相信，药房参与、医疗服务提供者互联以及技术赋能的护理协调三者的融合，为改善患者预后创造了重要机遇，同时为独立药房开辟了新的经济机遇。通过与 Kare PharmTech 的此次试点合作，我们正在建立一套基础设施，旨在支持慢性病管理及远程患者监测项目中可扩展的患者参与模式。”Kare PharmTech 创始人兼首席执行官米塔尔·帕内拉补充道：“我们一直致力于构建一个运营高效的 MSO 平台，能够为医疗服务提供者提供护理协调和报销工作流支持。通过与Wellgistics Health及其药房网络合作，我们相信能够进一步扩大患者参与度、提升护理连续性，并为未来医疗服务提供者的业务增长构建可扩展的框架。”双方指出，随着扩展工作的持续推进，该试点项目仍需根据运营发展、医疗服务提供者的参与情况以及合规要求进行动态调整。关于 Wellgistics Health, Inc.Wellgistics Health（纳斯达克代码：WGRX）是一家健康信息技术领域的领导者，将专有的药房配药优化人工智能平台EinsteinRx™整合到其获得专利的基于区块链的智能合约平台PharmacyChain™中，以优化处方药配药流程。其集成平台连接了 6,500 多家药房（“Wellgistics 药房网络”）和 200 多家制造商，提供批发分销、数字处方路由、直接送达患者以及由人工智能驱动的枢纽服务，例如资格审核、用药依从性管理、新用户注册、预授权以及按需现金支付履约服务，以优化患者的用药获取渠道。Wellgistics 提供端到端解决方案，旨在为美国独立药房恢复处方药市场的可及性、透明度和信任。关于 Kare PharmTech, LLCKare Clinicals 隶属于 Kare PharmTech, LLC 旗下的企业生态系统，而 Kare PharmTech, LLC 由基兰·帕特尔（Kiran Patel）博士控制。帕特尔博士于 1992 年创立了医疗补助计划（Medicaid）服务提供商 WellCare，并于 2002 年以 2 亿美元的价格将其出售。2007年，帕特尔博士创立了America's 1st Choice Holdings，并收购了Freedom Health和Optimum Holdings。2017年，他将America's 1st Choice Holdings出售给Anthem, Inc.。帕特尔博士是一位知名慈善家，曾被《佛罗里达趋势》杂志评为“年度佛罗里达人”。前瞻性陈述本新闻稿包含《1995年私人证券诉讼改革法案》所界定的前瞻性陈述。前瞻性陈述包括关于本公司预期、信念、计划、目标、意图、战略、未来事件或业绩的陈述，包括关于与 Kare PharmTech 和 Kare Clinicals 开展试点合作所带来的潜在效益、可扩展性、扩展、商业化、服务提供商参与、报销机会、患者参与计划、运营能力及未来发展的陈述，以及 Wellgistics 药房网络在支持 CCM 和 RPM 计划方面预计将发挥的作用。诸如“预期”、“相信”、“可能”、“期望”、“打算”、“或许”、“计划”、“潜在”、“预测”、“寻求”、“应当”、“将”等词语及类似表述旨在识别前瞻性陈述。这些前瞻性陈述基于当前的预期和假设，涉及可能导致实际结果与这些陈述所表达或暗示的结果存在重大差异的风险和不确定性。此类风险和不确定性包括但不限于：与医疗服务提供者的采用和参与相关的风险、报销结果、患者参与度、运营执行、试点项目的可扩展性、监管和医疗保健合规性考虑、适用法律或报销政策的变更、市场对公司服务的接受度、竞争因素，以及公司建立和维持战略关系并成功实施其业务战略的能力。本新闻稿所述的试点合作具有探索性质，无法保证该举措将带来更广泛的商业关系、重大的收入机会或长期的运营成功。有关这些及其他风险的更多信息，可查阅本公司向美国证券交易委员会提交的文件，包括其中所载的风险因素。除法律要求外，本公司不承担因新信息、未来事件或其他原因而更新或修订任何前瞻性陈述的义务。Wellgistics 媒体与投资者联系方式媒体：media@wellgisticshealth.com投资者关系：IR@wellgisticshealth.com[1] MarketsandMarkets - 美国远程患者监测市场报告来源：Wellgistics Health, Inc. Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Highlights:According to third-party industry reports, the U.S. RPM market is currently $14 Billion alone and expected to reach approximately $29 Billion by 2030, representing a 12.6% CAGR, as healthcare providers continue shifting toward value-based and home-based care models¹Pilot initiative launched across multiple provider offices focused on chronic care management (CCM) and remote patient monitoring (RPM) through it's MSO infrastructureApproximately 1,500+ claims generated to date through the pilot infrastructure with expansion roadmap targeting additional providersWellgistics Pharmacy Network of 6,500+ independent pharmacies positioned to support patient engagement and care coordination initiativesParticipating pharmacists expected to gain access to new clinical service revenue opportunitiesTAMPA, FLA., May 13, 2026 - (ACN Newswire via SeaPRwire.com) - Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced a pilot collaboration with Kare PharmTech and Kare Clinicals integrating its MSO infrastructure to support chronic care management ("CCM") and remote patient monitoring ("RPM") services across participating provider offices. According to third-party industry reports, the U.S. RPM market is currently $14 Billion and expected to reach approximately $29 Billion by 2030, representing a 12.6% CAGR, as healthcare providers continue shifting toward value-based and home-based care models.¹The pilot program currently includes multiple provider offices, with Kare Clinicals MSO serving as the billing provider on behalf of participating offices and rendering providers. The initiative is designed to support patient engagement, care coordination, and longitudinal monitoring programs through scalable operational and technology-enabled workflows. All CCM and RPM services are expected to be furnished and billed by appropriately licensed providers and participating entities in accordance with applicable federal and state healthcare laws, reimbursement requirements, and payor program rules.The companies stated that the pilot infrastructure has already generated 1,500+ claims and is intended to serve as the foundation for broader expansion efforts targeting approximately additional providers over time. As part of the collaboration, Wellgistics Health intends to leverage its network of more than 6,500 independent pharmacies to help identify and support eligible patients who may benefit from CCM and RPM services. Participating pharmacies within the Wellgistics Pharmacy Network may also have opportunities to participate in clinical engagement initiatives associated with the program.Prashant Patel, President and CEO of Wellgistics Health, Inc., stated, "We believe the convergence of pharmacy engagement, provider connectivity, and technology-enabled care coordination represents a significant opportunity to improve patient outcomes while creating new economic opportunities for independent pharmacies. Through this pilot collaboration with Kare PharmTech, we are establishing infrastructure designed to support scalable patient engagement models across chronic care management and remote patient monitoring programs."Mital Panera, Founder and Chief Executive Officer of Kare PharmTech, added, "Our focus has been on building an operationally efficient MSO platform capable of supporting providers with care coordination and reimbursement workflows. By collaborating with Wellgistics Health and its pharmacy network, we believe we can further expand patient participation, improve continuity of care, and create a scalable framework for future provider growth."The companies noted that the pilot program remains subject to ongoing operational development, provider participation, and regulatory compliance considerations as expansion efforts continue.About Wellgistics Health, Inc.Wellgistics Health (NASDAQ:WGRX) is a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription drug dispensing journey. Its integrated platform connects 6,500+ pharmacies (the "Wellgistics Pharmacy Network") and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment as needed to optimize patient access. Wellgistics provides end-to-end solutions designed to restore access, transparency, and trust in the U.S. prescription drug market for independent pharmacies.About Kare PharmTech, LLCKare Clinicals is part of the larger ecosystem of companies owned by Kare PharmTech, LLC, a company controlled by Dr. Kiran Patel. Dr. Patel founded Medicaid provider WellCare in 1992 and sold it in 2002 for $200 million. In 2007, Dr. Patel founded America's 1st Choice Holdings and acquired Freedom Health and Optimum Holdings. In 2017, he sold America's 1st Choice Holdings to Anthem, Inc. Dr. Patel is a noted philanthropist and was named Floridian of the Year by Florida Trend Magazine.Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding the Company's expectations, beliefs, plans, objectives, intentions, strategies, future events, or performance, including statements regarding the potential benefits, scalability, expansion, commercialization, provider participation, reimbursement opportunities, patient engagement initiatives, operational capabilities, and future development of the pilot collaboration with Kare PharmTech and Kare Clinicals, as well as the anticipated role of the Wellgistics Pharmacy Network in supporting CCM and RPM initiatives. Words such as "anticipate," "believe," "could," "expect," "intend," "may," "plan," "potential," "project," "seek," "should," "will," and similar expressions are intended to identify forward-looking statements.These forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Such risks and uncertainties include, without limitation, risks relating to provider adoption and participation, reimbursement outcomes, patient engagement levels, operational execution, scalability of the pilot program, regulatory and healthcare compliance considerations, changes in applicable laws or reimbursement policies, market acceptance of the Company's services, competitive factors, and the Company's ability to develop and maintain strategic relationships and successfully implement its business strategy.The pilot collaboration described in this press release is exploratory in nature, and there can be no assurance that the initiative will result in expanded commercial relationships, material revenue opportunities, or long-term operational success.Additional information regarding these and other risks can be found in the Company's filings with the U.S. Securities and Exchange Commission, including the risk factors contained therein. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.Wellgistics Media & Investor ContactMedia: media@wellgisticshealth.comInvestor Relations: IR@wellgisticshealth.com[1] MarketsandMarkets - U.S. Remote Patient Monitoring Market ReportSOURCE: Wellgistics Health, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年5月13日 - (亚太商讯 via SeaPRwire.com) - 近日，标普全球（S&P Global）在其发布的最新简报中明确表示，预计国泰海通集团下属公司国泰君安国际控股有限公司（“国泰君安国际”、“公司”，股份代号：1788.HK）及其直接控股公司国泰海通金融控股有限公司（“国泰海通金控”）作为母公司国泰海通证券股份有限公司（“国泰海通”）核心子公司，将继续在集团国际化战略中发挥关键作用。标普全球在简报中指出，国泰君安国际与母公司在投资银行及财富管理领域的业务协同效应显著，进一步强化了其在集团内部的重要性。国际化发展为国泰海通的核心战略重点之一，国泰君安国际将继续在集团加强全球布局的过程中扮演关键角色。2025年，国泰君安国际及国泰海通金控分别实现利润增长284%及85%，分别占国泰海通证券当年净利润约3%及8%。这一强劲的财务表现，有力印证了公司对集团整体业务发展的贡献。标普全球预期，国泰君安国际未来两年仍将作为集团核心子公司之一，持续获得母公司支持，其发行人信用评级及“稳定”展望将与母公司保持同步。标普全球认为，公司可获得母公司稳定、及时的支持，包括在必要时通过国泰海通间接受益于上海政府的资源。这份简报充分反应了公司的现况及对未来发展的预期。国泰君安国际将坚定不移地配合集团国际化战略，持续提升自身的专业能力及与集团的业务协同效率，为国泰海通集团成为具备国际竞争力与市场引领力的一流投资银行作出贡献。注：本文内容基于标普全球评级于2026年5月5日发布的独立观点文件（Tear Sheet：Guotai Junan International Holdings Ltd. And Guotai Haitong Financial Holdings Ltd.），该文件不构成评级行动。关于国泰君安国际国泰海通集团下属公司国泰君安国际（股票代号：1788.HK），是中国证券公司国际化的先行者和引领者，公司是首家通过IPO于香港联合交易所主板上市的中资证券公司。国泰君安国际以香港为业务基地，并在新加坡、越南和澳门设立子公司，业务覆盖全球主要市场，为客户境外资产配置提供高质量、多元化的综合性金融服务，核心业务包括财富管理、机构投资者服务、企业融资服务、投资管理等。目前，国泰君安国际已分别获得穆迪和标准普尔授予“Baa2”及“BBB+”长期发行人评级，MSCI ESG“AAA”评级, Wind ESG“A”评级及商道融绿ESG“A”评级，同时其标普全球ESG评分领先全球81%同业。公司控股股东国泰海通证券（股票代号：601211.SH/2611.HK）为中国资本市场长期、持续、全面领先的综合金融服务商。更多关于国泰君安国际的信息请见:https://www.gtjai.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com